Cargando…

Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer

BACKGROUND: Lung cancer features extremely high rates of morbidity and mortality. Bronchoalveolar lavage fluid (BALF), obtained by bronchoscopy and bronchoalveolar perfusion, can provide information on the cellular components of the lung microenvironment to assist with diagnosis and treatment of lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Liu, Ziyu, Li, Shanyu, Wang, Manning, Dai, Dayou, Jing, Hongyu, Liu, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938754/
https://www.ncbi.nlm.nih.gov/pubmed/31696667
http://dx.doi.org/10.1111/1759-7714.13220
_version_ 1783484089686294528
author Zhang, Ying
Liu, Ziyu
Li, Shanyu
Wang, Manning
Dai, Dayou
Jing, Hongyu
Liu, Lingyun
author_facet Zhang, Ying
Liu, Ziyu
Li, Shanyu
Wang, Manning
Dai, Dayou
Jing, Hongyu
Liu, Lingyun
author_sort Zhang, Ying
collection PubMed
description BACKGROUND: Lung cancer features extremely high rates of morbidity and mortality. Bronchoalveolar lavage fluid (BALF), obtained by bronchoscopy and bronchoalveolar perfusion, can provide information on the cellular components of the lung microenvironment to assist with diagnosis and treatment of lung cancer. METHODS: BALF was performed using a flexible bronchofiberscope. Exosomes were collected by ultracentrifugation. ELISA detected the amount of E‐cadherin. Transmission electron microscopic, ELISA and WB were conducted to identify the existence of the exosomes. Transwell and Wound healing assays were used to detect the ability of migration and invasion. RESULTS: We identified the existence of exosomes in BALF. Furthermore, we observed larger amounts of E‐cadherin in the BALF obtained from patients with lung cancer than in the control obtained from the healthy side of pneumonia. Exosomes from lung cancer groups promoted the migration and invasion of A549 cancer cells. CONCLUSION: The exosomes from lung cancer BALF promoted the migration and invasion of A549 cancer cells by carrying E‐cadherin. E‐cadherin on the surface of exosomes may act through a VE‐cadherin dependent mechanism and induce lung cancer metastasis.
format Online
Article
Text
id pubmed-6938754
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-69387542020-01-06 Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer Zhang, Ying Liu, Ziyu Li, Shanyu Wang, Manning Dai, Dayou Jing, Hongyu Liu, Lingyun Thorac Cancer Original Articles BACKGROUND: Lung cancer features extremely high rates of morbidity and mortality. Bronchoalveolar lavage fluid (BALF), obtained by bronchoscopy and bronchoalveolar perfusion, can provide information on the cellular components of the lung microenvironment to assist with diagnosis and treatment of lung cancer. METHODS: BALF was performed using a flexible bronchofiberscope. Exosomes were collected by ultracentrifugation. ELISA detected the amount of E‐cadherin. Transmission electron microscopic, ELISA and WB were conducted to identify the existence of the exosomes. Transwell and Wound healing assays were used to detect the ability of migration and invasion. RESULTS: We identified the existence of exosomes in BALF. Furthermore, we observed larger amounts of E‐cadherin in the BALF obtained from patients with lung cancer than in the control obtained from the healthy side of pneumonia. Exosomes from lung cancer groups promoted the migration and invasion of A549 cancer cells. CONCLUSION: The exosomes from lung cancer BALF promoted the migration and invasion of A549 cancer cells by carrying E‐cadherin. E‐cadherin on the surface of exosomes may act through a VE‐cadherin dependent mechanism and induce lung cancer metastasis. John Wiley & Sons Australia, Ltd 2019-11-06 2020-01 /pmc/articles/PMC6938754/ /pubmed/31696667 http://dx.doi.org/10.1111/1759-7714.13220 Text en © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhang, Ying
Liu, Ziyu
Li, Shanyu
Wang, Manning
Dai, Dayou
Jing, Hongyu
Liu, Lingyun
Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title_full Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title_fullStr Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title_full_unstemmed Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title_short Upregulation of E‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
title_sort upregulation of e‐cadherin in bronchoalveolar lavage fluid‐derived exosomes in patients with lung cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938754/
https://www.ncbi.nlm.nih.gov/pubmed/31696667
http://dx.doi.org/10.1111/1759-7714.13220
work_keys_str_mv AT zhangying upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT liuziyu upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT lishanyu upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT wangmanning upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT daidayou upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT jinghongyu upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer
AT liulingyun upregulationofecadherininbronchoalveolarlavagefluidderivedexosomesinpatientswithlungcancer